Asenapine in the Treatment of Negative Symptoms of Schizophrenia: Clinical Trial Design and Rationale

Name: Asenapine in the Treatment of Negative Symptoms of Schizophrenia: Clinical Trial Design and Rationale
SKU: 2330
Price: 30.00 USD
Availability: InStock

$30.00

Asenapine in the Treatment of Negative Symptoms of Schizophrenia: Clinical Trial Design and Rationale

By Larry Alphs, MD, PhD, John Panagides, PhD, and Scott Lancaster, MS

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Category: Medworks Reprint Series Tags: asenapine, clinical-trial, negative-symptoms, schizophrenia, study-design

Description

Description

Asenapine in the Treatment of Negative Symptoms of Schizophrenia: Clinical Trial Design and Rationale

By Larry Alphs, MD, PhD, John Panagides, PhD, and Scott Lancaster, MS

PB-40-2-06-Alphs

Asenapine in the Treatment of Negative Symptoms of Schizophrenia: Clinical Trial Design and Rationale

Description

Clinical Predictors of Response to Clozapine by Rajkumar A.P.

Cariprazine Augmentation to Antidepressant Therapy in Major Depressive Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled Trial

Treatment with Olanzapine: Early Predictors of Weight Gain Risk

Quetiapine XR Randomized, Double-Blind Study by Arifulla Khan

Asenapine in the Treatment of Negative Symptoms of Schizophrenia: Clinical Trial Design and Rationale

Description

Related products

Clinical Predictors of Response to Clozapine by Rajkumar A.P.

Cariprazine Augmentation to Antidepressant Therapy in Major Depressive Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled Trial

Treatment with Olanzapine: Early Predictors of Weight Gain Risk

Quetiapine XR Randomized, Double-Blind Study by Arifulla Khan